BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15581168)

  • 21. Should "indeterminate" diagnoses be used for thyroid fine-needle aspirates of nodules smaller than 1 cm?
    Renshaw AA; Gould EW
    Arch Pathol Lab Med; 2013 Nov; 137(11):1627-9. PubMed ID: 24168500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specimen adequacy and diagnostic specificity of ultrasound-guided fine needle aspirations of nonpalpable thyroid nodules.
    Kelly NP; Lim JC; DeJong S; Harmath C; Dudiak C; Wojcik EM
    Diagn Cytopathol; 2006 Mar; 34(3):188-90. PubMed ID: 16470862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
    Mehrotra P; Okpokam A; Bouhaidar R; Johnson SJ; Wilson JA; Davies BR; Lennard TW
    Histopathology; 2004 Nov; 45(5):493-500. PubMed ID: 15500653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomerase activity and telomere length in thyroid neoplasia: biological and clinical implications.
    Matthews P; Jones CJ; Skinner J; Haughton M; de Micco C; Wynford-Thomas D
    J Pathol; 2001 Jun; 194(2):183-93. PubMed ID: 11400147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
    Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
    J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms.
    Saji M; Xydas S; Westra WH; Liang CK; Clark DP; Udelsman R; Umbricht CB; Sukumar S; Zeiger MA
    Clin Cancer Res; 1999 Jun; 5(6):1483-9. PubMed ID: 10389936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy.
    Ha EJ; Baek JH; Lee JH; Song DE; Kim JK; Shong YK; Hong SJ
    Thyroid; 2013 Jun; 23(6):703-8. PubMed ID: 23544697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR.
    Jin L; Lloyd RV; Nassar A; Lappinga PJ; Sebo TJ; Swartz K; Seys AR; Erickson-Johnson MR; Roth CW; Evers BR; Oliveira AM; Zhang J
    Diagn Mol Pathol; 2011 Jun; 20(2):71-80. PubMed ID: 21532495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumors.
    Umbricht CB; Conrad GT; Clark DP; Westra WH; Smith DC; Zahurak M; Saji M; Smallridge RC; Goodman S; Zeiger MA
    Clin Cancer Res; 2004 Sep; 10(17):5762-8. PubMed ID: 15355904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fine needle aspiration cytology of thyroid gland diseases.
    Altavilla G; Pascale M; Nenci I
    Acta Cytol; 1990; 34(2):251-6. PubMed ID: 2321461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
    Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
    Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular classification of thyroid nodules by cytology.
    Pagedar NA; Chen DH; Wasman JK; Savvides P; Schluchter MD; Wilhelm SM; Lavertu P
    Laryngoscope; 2008 Apr; 118(4):692-6. PubMed ID: 18094649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens.
    Kelman AS; Rathan A; Leibowitz J; Burstein DE; Haber RS
    Thyroid; 2001 Mar; 11(3):271-7. PubMed ID: 11327619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diagnostic value of fine needle aspiration cytology in thyroid swellings in a university hospital, Yemen.
    Al-Hureibi KA; Al-Hureibi AA; Abdulmughni YA; Aulaqi SM; Salman MS; Al-Zooba EM
    Saudi Med J; 2003 May; 24(5):499-503. PubMed ID: 12847625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomerase is a highly sensitive and specific molecular marker in fine-needle aspirates of breast lesions.
    Poremba C; Shroyer KR; Frost M; Diallo R; Fogt F; Schäfer KL; Bürger H; Shroyer AL; Dockhorn-Dworniczak B; Boecker W
    J Clin Oncol; 1999 Jul; 17(7):2020-6. PubMed ID: 10561253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular swirls in fine needle aspirates of papillary thyroid carcinoma: a new diagnostic criterion.
    Szporn AH; Yuan S; Wu M; Burstein DE
    Mod Pathol; 2006 Nov; 19(11):1470-3. PubMed ID: 16951672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A comparative study of cytological and histological studies of the thyroid gland].
    Emmrich P; Gauer G; Gauer J; Mättig H; Rosenkranz M
    Zentralbl Chir; 2001 Apr; 126(4):267-72. PubMed ID: 11370387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
    Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
    Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomerase activity in surgical specimens and fine-needle aspiration biopsies from hyperplastic and neoplastic human thyroid tissues.
    Trulsson LM; Velin AK; Herder A; Söderkvist P; Rüter A; Smeds S
    Am J Surg; 2003 Jul; 186(1):83-8. PubMed ID: 12842757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fine-needle aspiration biopsy of papillary thyroid carcinoma: diagnostic utility of cytokeratin 19 immunostaining.
    Nasser SM; Pitman MB; Pilch BZ; Faquin WC
    Cancer; 2000 Oct; 90(5):307-11. PubMed ID: 11038428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.